Cargando…
Cefepime extended infusion versus intermittent infusion: Clinical and cost evaluation
BACKGROUND: Extended infusion cefepime (1 gram every 6 hours administered over 3 hours) achieves pharmacodynamic efficacy against bacteria with a MIC of ≤8 mg/L in Monte Carlo simulations. This regimen has not been evaluated in clinical practice. OBJECTIVE: Compare clinical and economic outcomes for...
Autores principales: | Khole, Aalok V., Dionne, Emily, Zitek-Morrison, Emily, Campion, Maureen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369431/ https://www.ncbi.nlm.nih.gov/pubmed/37502254 http://dx.doi.org/10.1017/ash.2023.179 |
Ejemplares similares
-
Cefepime in critically ill patients: continuous infusion versus intermittent regimen
por: Georges, B, et al.
Publicado: (2001) -
Outcomes of Intravenous Push versus Intermittent Infusion Administration of Cefepime in Critically Ill Patients
por: Smith, Susan E., et al.
Publicado: (2023) -
Extended infusion versus intermittent infusion of imipenem in the treatment of ventilator-associated pneumonia
por: Ibrahim, Mohamed M, et al.
Publicado: (2017) -
1306. Comparison of the Use of Extended and Intermittent Infusion Cefepime and Piperacillin/tazobactam in Non-critically Ill, Obese Patients
por: Marg, Carolyn, et al.
Publicado: (2020) -
Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study
por: Naiim, Christina Medhat, et al.
Publicado: (2022)